Cargando…

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients

Cancer patients are a vulnerable population postulated to be at higher risk for severe COVID-19 infection. Increased COVID-19 morbidity and mortality in cancer patients may be attributable to age, comorbidities, smoking, healthcare exposure, and cancer treatments, and partially to the cancer itself....

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lova, Surya, Sanjna, Le, Anh N., Desai, Heena, Doucette, Abigail, Gabriel, Peter, Ritchie, Marylyn, Rader, Daniel, Maillard, Ivan, Bange, Erin, Huang, Alexander, Vonderheide, Robert H., DeMichele, Angela, Verma, Anurag, Mamtani, Ronac, Maxwell, Kara N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430598/ https://www.ncbi.nlm.nih.gov/pubmed/32817956 http://dx.doi.org/10.1101/2020.08.14.20174961

Ejemplares similares

Rates of COVID-19–Related Outcomes in Cancer Compared With Noncancer Patients
por: Sun, Lova, et al.
Publicado: (2021)

Performance of polygenic risk scores for cancer prediction in a racially diverse academic biobank
por: Wang, Louise, et al.
Publicado: (2022)

Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors
por: Bange, Erin M., et al.
Publicado: (2022)

Association Between US Administration Endorsement of Hydroxychloroquine for COVID-19 and Outpatient Prescribing
por: Harrigan, James J., et al.
Publicado: (2020)

Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer
por: Lee, Daniel J., et al.
Publicado: (2022)

Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic ATM Alterations
por: Hannan, Zain, et al.
Publicado: (2021)

Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study
por: Gotschall, Jeromy W., et al.
Publicado: (2022)

Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer
por: Narayan, Vivek, et al.
Publicado: (2016)

Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
por: Vader, Daniel T, et al.
Publicado: (2022)

Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone
por: Marar, Mallika, et al.
Publicado: (2022)

Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
por: Mamtani, Ronac, et al.
Publicado: (2023)

Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival
por: Boursi, Ben, et al.
Publicado: (2023)

The genetic and phenotypic correlates of mtDNA copy number in a multi-ancestry cohort
por: Zaidi, Arslan A., et al.
Publicado: (2023)

Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
por: Parikh, Ravi B., et al.
Publicado: (2023)

Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023)

Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study
por: Mamtani, Ronac, et al.
Publicado: (2016)

CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer
por: Bange, Erin M., et al.
Publicado: (2021)

Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas
por: Mamtani, Ronac, et al.
Publicado: (2014)

A simulation study investigating power estimates in phenome-wide association studies
por: Verma, Anurag, et al.
Publicado: (2018)

Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression()
por: Li, Binglan, et al.
Publicado: (2018)

Long-term Survival After Treating Cardiac Metastasis With Radiation and Immune Therapy: A Case Report
por: Arscott, W. Tristram, et al.
Publicado: (2018)

Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation
por: Vader, Daniel T., et al.
Publicado: (2023)

Radiomics-guided therapy for bladder cancer: Using an optimal biomarker approach to determine extent of bladder cancer invasion from t2-weighted magnetic resonance images
por: Tong, Yubing, et al.
Publicado: (2018)

A Natural Language Processing–Assisted Extraction System for Gleason Scores: Development and Usability Study
por: Yu, Shun, et al.
Publicado: (2021)

Influence of tissue context on gene prioritization for predicted transcriptome-wide association studies
por: Li, Binglan, et al.
Publicado: (2019)

Another Round of “Clue” to Uncover the Mystery of Complex Traits
por: Verma, Shefali Setia, et al.
Publicado: (2018)

A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data
por: Kern, David M, et al.
Publicado: (2017)

Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202
por: Verma, Anurag, et al.
Publicado: (2017)

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018
por: Parikh, Ravi B., et al.
Publicado: (2020)

Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer
por: Vonderheide, Robert H., et al.
Publicado: (2020)

Rare variants in drug target genes contributing to complex diseases, phenome-wide
por: Verma, Shefali Setia, et al.
Publicado: (2018)

Author Correction: Rare variants in drug target genes contributing to complex diseases, phenome-wide
por: Verma, Shefali Setia, et al.
Publicado: (2018)

Acute respiratory distress syndrome: A study of autopsy findings
por: Saha, Anurag, et al.
Publicado: (2021)

Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma
por: Doshi, Gurjyot K., et al.
Publicado: (2023)

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer
por: Maxwell, Kara N., et al.
Publicado: (2014)

Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT
por: Boursi, Ben, et al.
Publicado: (2018)

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022)

Using prior knowledge and genome-wide association to identify pathways involved in multiple sclerosis
por: Ritchie, Marylyn D
Publicado: (2009)

The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era
por: Ritchie, Marylyn D.
Publicado: (2012)

Erratum to: The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era
por: Ritchie, Marylyn D.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_944krgorggg771oaat2fket4rr